JP2020186273A5 - - Google Patents

Download PDF

Info

Publication number
JP2020186273A5
JP2020186273A5 JP2020140050A JP2020140050A JP2020186273A5 JP 2020186273 A5 JP2020186273 A5 JP 2020186273A5 JP 2020140050 A JP2020140050 A JP 2020140050A JP 2020140050 A JP2020140050 A JP 2020140050A JP 2020186273 A5 JP2020186273 A5 JP 2020186273A5
Authority
JP
Japan
Prior art keywords
pge
container
composition
composition according
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2020140050A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020186273A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2020186273A publication Critical patent/JP2020186273A/ja
Publication of JP2020186273A5 publication Critical patent/JP2020186273A5/ja
Withdrawn legal-status Critical Current

Links

JP2020140050A 2009-03-19 2020-08-21 サイクリックampエンハンサーおよび/またはepリガンドを含む組成物、ならびにこれを調製および使用する方法 Withdrawn JP2020186273A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16171709P 2009-03-19 2009-03-19
US61/161,717 2009-03-19
US24876509P 2009-10-05 2009-10-05
US61/248,765 2009-10-05

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018177292A Division JP2018199724A (ja) 2009-03-19 2018-09-21 サイクリックampエンハンサーおよび/またはepリガンドを含む組成物、ならびにこれを調製および使用する方法

Publications (2)

Publication Number Publication Date
JP2020186273A JP2020186273A (ja) 2020-11-19
JP2020186273A5 true JP2020186273A5 (https=) 2021-07-26

Family

ID=42740238

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2012500968A Expired - Fee Related JP5836262B2 (ja) 2009-03-19 2010-03-18 サイクリックampエンハンサーおよび/またはepリガンドを含む組成物、ならびにこれを調製および使用する方法
JP2015094512A Expired - Fee Related JP6177273B2 (ja) 2009-03-19 2015-05-05 サイクリックampエンハンサーおよび/またはepリガンドを含む組成物、ならびにこれを調製および使用する方法
JP2017047351A Withdrawn JP2017105840A (ja) 2009-03-19 2017-03-13 サイクリックampエンハンサーおよび/またはepリガンドを含む組成物、ならびにこれを調製および使用する方法
JP2018177292A Withdrawn JP2018199724A (ja) 2009-03-19 2018-09-21 サイクリックampエンハンサーおよび/またはepリガンドを含む組成物、ならびにこれを調製および使用する方法
JP2020140050A Withdrawn JP2020186273A (ja) 2009-03-19 2020-08-21 サイクリックampエンハンサーおよび/またはepリガンドを含む組成物、ならびにこれを調製および使用する方法

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP2012500968A Expired - Fee Related JP5836262B2 (ja) 2009-03-19 2010-03-18 サイクリックampエンハンサーおよび/またはepリガンドを含む組成物、ならびにこれを調製および使用する方法
JP2015094512A Expired - Fee Related JP6177273B2 (ja) 2009-03-19 2015-05-05 サイクリックampエンハンサーおよび/またはepリガンドを含む組成物、ならびにこれを調製および使用する方法
JP2017047351A Withdrawn JP2017105840A (ja) 2009-03-19 2017-03-13 サイクリックampエンハンサーおよび/またはepリガンドを含む組成物、ならびにこれを調製および使用する方法
JP2018177292A Withdrawn JP2018199724A (ja) 2009-03-19 2018-09-21 サイクリックampエンハンサーおよび/またはepリガンドを含む組成物、ならびにこれを調製および使用する方法

Country Status (4)

Country Link
US (1) US20120202288A1 (https=)
EP (2) EP2408444A4 (https=)
JP (5) JP5836262B2 (https=)
WO (1) WO2010108028A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108379292A (zh) 2008-11-06 2018-08-10 印第安纳大学研究与技术公司 增强造血干细胞植入过程的材料和方法
WO2010108028A2 (en) * 2009-03-19 2010-09-23 Fate Therapeutics, Inc. Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same
US11459545B2 (en) 2009-11-15 2022-10-04 Indiana University Research And Technology Corporation Methods to enhance delivery and engraftment of stem cells including the identification of specific prostaglandin E2 receptors
US10213464B2 (en) * 2011-01-13 2019-02-26 Scipharm Sarl Method for enhancing engraftment of haematopoetic stem cells
ES2769270T3 (es) 2011-09-30 2020-06-25 Bluebird Bio Inc Compuestos para transducción viral mejorada
JP6220791B2 (ja) 2011-12-02 2017-10-25 フェイト セラピューティクス,インコーポレイテッド 増強された幹細胞組成物
EP2785350B1 (en) 2011-12-02 2018-05-02 Fate Therapeutics, Inc. Improved methods of treating ischemia
WO2014150602A1 (en) 2013-03-15 2014-09-25 Fate Therapeutics, Inc. Cell potency assay for therapeutic potential
US9943545B2 (en) * 2013-03-15 2018-04-17 Fate Therapeutics, Inc. Stem cell culture media and methods of enhancing cell survival
WO2014153363A1 (en) * 2013-03-18 2014-09-25 Northeastern University Method for generation of broadly neutralizing anti-pathogen antibodies
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
CN104614455B (zh) * 2014-12-25 2016-10-05 上海景峰制药有限公司 一种前列地尔注射液的含量检测方法
US20180112180A1 (en) 2015-01-26 2018-04-26 Fate Therapeutics, Inc. Cells with increased immuno-regulatory properties and methods for their use and manufacture
US20180214487A1 (en) 2015-07-21 2018-08-02 The Children's Medical Center Corporation Pd-l1 expressing hematopoietic stem cells and uses
IL261002B2 (en) 2016-02-12 2024-07-01 Bluebird Bio Inc Vcn enhancer compositions and methods of using the same
WO2017139561A1 (en) 2016-02-12 2017-08-17 Bluebird Bio, Inc. Vcn enhancer compositions and methods of using the same
US11879137B2 (en) 2017-09-22 2024-01-23 The Children's Medical Center Corporation Treatment of type 1 diabetes and autoimmune diseases or disorders
EP4706758A3 (en) 2019-05-21 2026-05-06 Ardelyx, Inc. Methods for inhibiting phosphate transport
EP4146797A1 (en) 2020-05-06 2023-03-15 Orchard Therapeutics (Europe) Limited Treatment for neurodegenerative diseases
CN114854674B (zh) * 2022-06-20 2025-01-24 中国农业大学 dbcAMP在制备原始卵泡体外激活剂中的应用
CN115636776B (zh) * 2022-10-10 2024-05-07 厦门欧瑞捷生物科技有限公司 一种以PGF2α合成中的副产物为原料合成前列地尔的方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790840A (fr) * 1971-11-01 1973-04-30 Upjohn Co Solutions de medicaments instables et leur preparation
US5004681B1 (en) * 1987-11-12 2000-04-11 Biocyte Corp Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US5753516A (en) * 1995-02-03 1998-05-19 Heagy; Wyrta E. Screening method for ligands of the EBI-1 receptor
US6440734B1 (en) * 1998-09-25 2002-08-27 Cytomatrix, Llc Methods and devices for the long-term culture of hematopoietic progenitor cells
AU2183900A (en) 1998-12-24 2000-07-31 Alcon Laboratories, Inc. Ep4 receptor agonists for treatment of dry eye
HK1048302A1 (zh) 1999-08-13 2003-03-28 大正制药株式会社 前列腺素衍生物
DE60120007T2 (de) 2000-01-31 2006-11-16 Pfizer Products Inc., Groton Verwendung von Aktivatoren des Prostaglandinrezeptores 4 zur Behandlung von akuter oder chronischer Niereninsuffizienz
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
FR2825261B1 (fr) 2001-06-01 2003-09-12 Maco Pharma Sa Ligne de prelevement du sang placentaire comprenant une poche de rincage
US7179643B2 (en) * 2001-06-14 2007-02-20 Reliance Life Sciences Pvt. Ltd. Device and a process for expansion of haemopoeitic stem cells for therapeutic use
JP2003093048A (ja) * 2001-09-26 2003-04-02 Asahi Kasei Corp 新規細胞製剤製造用培養媒体
US6747037B1 (en) 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs
US20050032122A1 (en) * 2003-08-06 2005-02-10 Shiaw-Min Hwang Optimizing culture medium for CD34<+> hematopoietic cell expansion
GB0329620D0 (en) 2003-12-22 2004-01-28 Pharmagene Lab Ltd EP2 receptor agonists
WO2005065396A2 (en) * 2003-12-31 2005-07-21 Osteotech, Inc. Improved bone matrix compositions and methods
US7147626B2 (en) 2004-09-23 2006-12-12 Celgene Corporation Cord blood and placenta collection kit
JP2008518013A (ja) 2004-10-26 2008-05-29 アラーガン、インコーポレイテッド プロスタグランジンep4アゴニストによる処置方法およびデリバリー方法
DE102005062741A1 (de) 2005-12-22 2007-06-28 Bayer Schering Pharma Ag Fluorene und Carbazole als Liganden des EP2 Rezeptors
RU2425876C2 (ru) * 2006-03-24 2011-08-10 Чилдрен'З Медикал Сентер Корпорейшн Способ модулирования роста гематопоэтических стволовых клеток
EP2094839B1 (en) * 2006-12-08 2020-02-05 University of Rochester Expansion of hematopoietic stem cells
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
WO2010108028A2 (en) * 2009-03-19 2010-09-23 Fate Therapeutics, Inc. Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same

Similar Documents

Publication Publication Date Title
JP2020186273A5 (https=)
JP2012521349A5 (https=)
JP2015180645A5 (https=)
Lowe Engineering blood: synthetic substitutes from fluorinated compounds
RU2491072C2 (ru) Композиции для лечения легочной гипертензии, вводимые путем ингаляции, и способы их применения
Kaisers et al. Liquid ventilation
Ashbaugh et al. Acute respiratory distress in adults
JP5778384B2 (ja) エスモロール処方物
US20140010848A1 (en) Gas-filled microbubbles and systems for gas delivery
CN110050782A (zh) 一种干细胞冻存液及其制备方法和冻存方法
JP2010155842A5 (https=)
JP2005533021A5 (https=)
CN112753694A (zh) 一种细胞冻存液和用于间充质干细胞的冷冻方法及其应用
JP2007532619A (ja) 懸濁したガラス粒子を含有する液体
PT90030B (pt) Processo para a preparacao de liofilisado de ifosfamida e mesna
JP3049366B2 (ja) 造影剤
ES2425581T3 (es) Composiciones farmacéuticas para el tratamiento de la arteriopatía capilar
JPH0322850B2 (https=)
JP2008517063A (ja) A2aアデノシンレセプターアゴニストの使用
HOWLETT et al. Fluid fluorocarbon as oxygenator in experimental extracorporeal circulation
Wellens et al. Combined heart-lung transplantation for terminal pulmonary lymphangioleiomyomatosis
CN106821982A (zh) 一种西那普肽微泡制剂及其制备方法
US3826823A (en) Stabilized prostaglandin preparations
JP6165986B2 (ja) ボルテゾミブを含む医薬組成物
CN101015702A (zh) 一种新型的脂质超声造影冻干制剂及其制备方法